Receptor
From Proteopedia
(Difference between revisions)
Line 41: | Line 41: | ||
**[[Adrenergic receptor|Adrenergic receptors in general]] | **[[Adrenergic receptor|Adrenergic receptors in general]] | ||
**[[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]] | **[[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]] | ||
- | **Dobutamine, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y00]], [[2y01]], [[6h7l]] | + | **Dobutamine, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y00]], [[2y01]], [[6h7l]] |
- | **Isoprenaline, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y03]] | + | **Isoprenaline, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y03]] |
+ | **Carmoterol, see [[2y02]] | ||
+ | **Salbutamol (Albuterol in USA), [[2y04]] | ||
**The human β2 adrenergic receptor bound to a G-protein ([[3sn6]]) is featured in a scene above, and additional structures are on the [[Adrenergic receptor|Adrenergic receptor page]]. | **The human β2 adrenergic receptor bound to a G-protein ([[3sn6]]) is featured in a scene above, and additional structures are on the [[Adrenergic receptor|Adrenergic receptor page]]. | ||
**[[Beta-2 Adrenergic Receptor|Article Beta-2 Adrenergic Receptor by Wayne Decatur, David Canner, Dotan Shaniv, Joel L. Sussman, Michal Harel]] | **[[Beta-2 Adrenergic Receptor|Article Beta-2 Adrenergic Receptor by Wayne Decatur, David Canner, Dotan Shaniv, Joel L. Sussman, Michal Harel]] | ||
Line 48: | Line 50: | ||
**[[Group:SMART:A Physical Model of the beta-Adrenergic Receptor]] | **[[Group:SMART:A Physical Model of the beta-Adrenergic Receptor]] | ||
**G<sub>s</sub>: adenylate cyclase activated, cAMP up. For G<sub>s</sub> see [[Beta2 adrenergic receptor-Gs protein complex updated]] | **G<sub>s</sub>: adenylate cyclase activated, cAMP up. For G<sub>s</sub> see [[Beta2 adrenergic receptor-Gs protein complex updated]] | ||
+ | **[[Dopamine receptor|Dopamine receptors 1 page]] | ||
+ | **[[Dopamine Receptors|Dopamine receptors 2 page]] | ||
+ | **[[Histamine H1 receptor]] | ||
+ | **[[3rze]] - human histamine H1 receptor with an antagonist doxepin | ||
+ | **[[Adenosine A2A receptor]] | ||
+ | **[[Caffeine|Effect of Caffeine (Trimethylxanthine) on Human A2A Receptor]] | ||
+ | **[[Adenosine A2A receptor 3D structures]] | ||
+ | **[[Muscarinic acetylcholine receptor]] | ||
+ | **[[Glucose-dependent Insulinotropic Polypeptide Receptor]] | ||
+ | **[[Glucagon receptor]] | ||
+ | **[[Glucagon-like peptide 1 receptor]] | ||
+ | **[[Metabotropic glutamate receptor|Metabotropic Glutamate Receptors]] | ||
+ | **[[Ligand Binding N-Terminal of Metabotropic Glutamate Receptors]] | ||
+ | **[[Metabotropic glutamate receptor 5]] | ||
==Kinase-linked, enzyme-linked and related receptors== | ==Kinase-linked, enzyme-linked and related receptors== |
Revision as of 13:58, 8 April 2021
|
References
- ↑ De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
- ↑ Segaliny AI, Tellez-Gabriel M, Heymann MF, Heymann D. Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. J Bone Oncol. 2015 Jan 23;4(1):1-12. doi: 10.1016/j.jbo.2015.01.001. eCollection , 2015 Mar. PMID:26579483 doi:http://dx.doi.org/10.1016/j.jbo.2015.01.001